Quan Liu

Dr. Quan Liu

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
QLQuan Liu
Quan Liu
BHBiao He
Biao He
SHSi-Yang Huang
Si-Yang Huang
FWFeng Wei
Feng Wei
XZXing-Quan Zhu
Xing-Quan Zhu

28 May 2015 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
QLQuan Liu
Quan Liu
ZWZe-Dong Wang
Ze-Dong Wang
Si-Yang HuangSi-Yang Huang
Si-Yang Huang
XZXing-Quan Zhu
Xing-Quan Zhu
Toxoplasmosis, caused by the obligate intracellular protozoan Toxoplasma gondii, is an important zoonosis with medical and veterinary importance worldwide. The disease is mainly contracted by ingesting undercooked or raw meat containing viable tissue cysts, or by ingesting food or water contaminated with oocysts. The diagnosis and genetic characterization of T. gondii infection is crucial for the surveillance, prevention and control of toxoplasmosis. Traditional approaches for the diagnosis of toxoplasmosis include etiological, immunological and imaging techniques. Diagnosis of toxoplasmosis has been improved by the emergence of molecular technologies to amplify parasite nucleic acids. Among these, polymerase chain reaction (PCR)-based molecular techniques have been useful for the genetic characterization of T. gondii. Serotyping methods based on polymorphic polypeptides have the potential to become the choice for typing T. gondii in humans and animals. In this review, we summarize conventional non-DNA-based diagnostic methods, and the DNA-based molecular techniques for the diagnosis and genetic characterization of T. gondii. These techniques have provided foundations for further development of more effective and accurate detection of T. gondii infection. These advances will contribute to an improved understanding of the epidemiology, prevention and control of toxoplasmosis.

1 April 2017 in The Lancet HIV
Verified
Journal Article
Closed access
ZWZe-Dong Wang
Ze-Dong Wang
SWShuchao Wang
Shuchao Wang
HLHuan-Huan Liu
Huan-Huan Liu
HMHong-Yu Ma
Hong-Yu Ma
ZLZhong-Yu Li
Zhong-Yu Li
QLQuan Liu
Quan Liu

30 May 2019 in New England Journal of Medicine
Verified
Journal Article
Closed access
ZWZe-Dong Wang
Ze-Dong Wang
BWBo Wang
Bo Wang
FWFeng Wei
Feng Wei
SHShu-Zheng Han
Shu-Zheng Han
LZLi Zhang
Li Zhang
QLQuan Liu
Quan Liu
In 2017, surveillance for tickborne diseases in China led to the identification of a patient who presented to a hospital in Inner Mongolia with a febrile illness that had an unknown cause. The clinical manifestation of the illness was similar to that of tickborne encephalitis virus (TBEV) infection, but neither TBEV RNA nor antibodies against the virus were detected.

13 June 2018 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
JCJia Chen
Jia Chen
QLQuan Liu
Quan Liu
GLGuo-Hua Liu
Guo-Hua Liu
WZWen-Bin Zheng
Wen-Bin Zheng
SHSung-Tae Hong
Sung-Tae Hong
HEHany Elsheikha
Hany Elsheikha
Toxocariasis is a neglected parasitic zoonosis that afflicts millions of the pediatric and adolescent populations worldwide, especially in impoverished communities. This disease is caused by infection with the larvae of Toxocara canis and T. cati, the most ubiquitous intestinal nematode parasite in dogs and cats, respectively. In this article, recent advances in the epidemiology, clinical presentation, diagnosis and pharmacotherapies that have been used in the treatment of toxocariasis are reviewed. Over the past two decades, we have come far in our understanding of the biology and epidemiology of toxocariasis. However, lack of laboratory infrastructure in some countries, lack of uniform case definitions and limited surveillance infrastructure are some of the challenges that hindered the estimation of global disease burden. Toxocariasis encompasses four clinical forms: visceral, ocular, covert and neural. Incorrect or misdiagnosis of any of these disabling conditions can result in severe health consequences and considerable medical care spending. Fortunately, multiple diagnostic modalities are available, which if effectively used together with the administration of appropriate pharmacologic therapies, can minimize any unnecessary patient morbidity. Although progress has been made in the management of toxocariasis patients, there remains much work to be done. Implementation of new technologies and better understanding of the pathogenesis of toxocariasis can identify new diagnostic biomarkers, which may help in increasing diagnostic accuracy. Also, further clinical research breakthroughs are needed to develop better ways to effectively control and prevent this serious disease.

9 March 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
ZWZe-Dong Wang
Ze-Dong Wang
HLHuan-Huan Liu
Huan-Huan Liu
ZMZhan-Xi Ma
Zhan-Xi Ma
HMHong-Yu Ma
Hong-Yu Ma
ZLZhong-Yu Li
Zhong-Yu Li
QLQuan Liu
Quan Liu
Toxoplasma gondii has been suggested as an important opportunistic pathogen in immunocompromised patients. We conducted a global meta-analysis to assess the prevalence and odds ratios (ORs) of T. gondii infection in immunocompromised individuals. Electronic databases were reviewed for T. gondii infection in HIV/AIDS patients, cancer patients, and transplant recipients, and meta-analyses were conducted to calculate overall estimated prevalence and ORs using random-effects models. Totally, 72 eligible studies were included. The estimated pooled prevalence of T. gondii infection in immunocompromised patients and the control was 35.9% and 24.7% (p0.05), whose estimated pooled ORs were 2.03, 2.89, and 1.51 (95% CI, 1.16–1.95), respectively. This study is the first to demonstrate that the immunocompromised patients are associated with higher odds of T. gondii infection, and appropriate prevention and control measures are highly recommended for these susceptible populations.